SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001509190-19-000029
Filing Date
2019-04-19
Accepted
2019-04-19 16:17:47
Documents
5
Effectiveness Date
2019-04-19

Document Format Files

Seq Description Document Type Size
1 DEFA14A petx-20190419xdefa14a.htm DEFA14A 103060
2 GRAPHIC petx-20190419xdefa14ag001.jpg GRAPHIC 73185
3 GRAPHIC petx-20190419xdefa14ag002.jpg GRAPHIC 131465
4 GRAPHIC petx-20190419xdefa14ag003.jpg GRAPHIC 41572
5 GRAPHIC petx-20190419xdefa14ag004.jpg GRAPHIC 5946
  Complete submission text file 0001509190-19-000029.txt   451970
Mailing Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211
Business Address 11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD KS 66211 913.353.1000
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35952 | Film No.: 19758091
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1